desogestrel progestin medication used birth control pills also used treatment menopausal symptoms medication available used alone combination taken side effects desogestrel include menstrual irregularities headaches nausea breast tenderness mood changes acne increased hair growth desogestrel progestin synthetic progestogen hence agonist progesterone receptor biological target progestogens like weak androgenic glucocorticoid activity important hormonal medication prodrug etonogestrel desogestrel discovered introduced medical use europe became available united states desogestrel sometimes referred thirdgeneration along norethisterone one progestins widely available progestogenonly mini pill birth desogestrel marketed widely throughout available generic version ethinylestradiol commonly prescribed medication united states million desogestrel used hormonal contraception women specifically birth control used alone progestogenonly pills mini pills combination estrogen ethinylestradiol combined oral contraceptive desogestrel norethisterone progestins widely used progestogenonly mini also newergeneration progestin reduced androgenic activity used addition hormonal contraception desogestrel used combination estrogens estradiol component menopausal hormone medication also used treatment desogestrel available alone form μg oral tablets dose μg combination μg ethinylestradiol oral formulations indicated specifically contraceptive contraindications desogestrel desogestrel indicated use contraindicated lactation common side effects desogestrel may include menstrual irregularities amenorrhea headaches nausea breast tenderness mood changes eg depression well weight gain acne however also reported adversely affect addition acne hirsutism negligible combined ethinylestradiol combination actually used treat desogestrel also cause changes total ldltooltip lowdensity lipoprotein hdltooltip highdensity lipoprotein uncommon side effects desogestrel may include vaginal infection contact lens intolerance vomiting hair loss dysmenorrhea ovarian cysts fatigue rare side effects include rash urticaria erythema breast discharge ectopic pregnancies aggravation angioedema may also occur serious side effects combined oral contraceptives containing desogestrel may include venous thromboembolism arterial thromboembolism hormonedependent tumors eg liver tumors breast cancer serious harmful effects reported overdose symptoms may include nausea vomiting young girls slight vaginal safety studies dosages μgday desogestrel women showed adverse effects laboratory various parameters produced reported subjective side antidote desogestrel overdose treatment based inducers liver enzymes increase metabolism desogestrel etonogestrel reduce circulating may result contraceptive examples liver enzyme inducers include barbiturates eg phenobarbital bosentan carbamazepine efavirenz phenytoin primidone rifampicin possibly also felbamate griseofulvin oxcarbazepine rifabutin st johns wort many antivirals hivaids hcv boceprevir nelfinavir nevirapine ritonavir telaprevir may increase decrease levels desogestrel inhibitors including strong inhibitors like clarithromycin itraconazole ketoconazole moderate inhibitors like diltiazem erythromycin fluconazole may increase levels desogestrel hormonal contraceptives may interfere metabolism drugs resulting increased levels eg ciclosporine decreased levels eg desogestrel prodrug etonogestrel via active metabolite progestogenic activity antigonadotropic effects weak androgenic activity weak glucocorticoid activity hormonal desogestrel progestogen agonist progesterone receptor inactive prodrug etonogestrel essentially affinity pr hence etonogestrel exclusively responsible effects etonogestrel affinity promegestone affinity progesterone desogestrel via etonogestrel potent progestogen inhibits ovulation low doses low microgram effective minimum dosage inhibition ovulation μgday desogestrel alone combination however studies combination oral estradiol suggested higher doses may desogestrel etonogestrel among potent progestogens available along gestodene levonorgestrel effective ovulationinhibiting dosages μgday μgday oral desogestrel clinically order times potent oral micronized progesterone effective ovulationinhibiting dosage mgday due progestogenic activity desogestrel potent functional antiestrogenic effects certain dosedependently antagonizes effects ethinylestradiol vaginal epithelium cervical mucus endometrium marked progestogenic effects occurring dosage rise body temperature women μgday women desogestrel also antigonadotropic effects similarly due progestogenic contraceptive effects desogestrel women mediated prevention ovulation via antigonadotropic effects also marked progestogenic antiestrogenic effects cervical mucus aside progestogenic activity desogestrel also offtarget hormonal activity steroid hormone receptors see however activities relatively weak desogestrel said one selective pure progestogens used oral desogestrel antigonadotropic effects via progestogenic activity similarly found reduce testosterone levels women dosage addition desogestrel extensively investigated antigonadotropin dosages μgday combination testosterone male contraceptive one study found μgday μgday desogestrel alone healthy young men suppressed luteinizing hormone lh levels respectively folliclestimulating hormone fsh levels respectively testosterone levels lh levels suppressed maximally desogestrel within days whereas days necessary maximal suppression fsh testosterone previous study authors found increasing dosage desogestrel μgday μgday resulted suppression gonadotropin addition low dose mgweek intramuscular testosterone enanthate weeks increased testosterone levels suppressed lh fsh levels limits assay detection ie undetectable nearundetectable levels μgday μgday desogestrel upon cessation treatment levels lh fsh testosterone recovered baseline values within etonogestrel affinity metribolone affinity levonorgestrel androgen receptor ar desogestrel affinity metabolite etonogestrel also affinity ar desogestrel via etonogestrel low androgenic potency methyltestosterone animal assays hence considered weak although etonogestrel affinity ar norethisterone due relatively increased progestogenic potency decreased androgenic activity etonogestrel drug markedly higher selectivity pr ar older progestins like norethisterone conversely selectivity pr ar similar newer progestins like gestodene estimated μgday desogestrel less onesixth androgenic effect mgday norethisterone common dosages drugs used combined oral clinical studies norethisterone even high dosages eg mgday observed mild androgenic effects minority women including acne increased sebum production hirsutism slight virilization female accordance weak androgenic activity desogestrel minimal effects lipid metabolism blood lipid profile although may still significant desogestrel also reduces sex hormonebinding globulin shbg levels given women alone combined μgday ethinylestradiol contrast strongly activates shbg production increase shbg desogestrel may slightly reduce ethinylestradiolinduced increases shbg however dosages used oral contraceptives combination ethinylestradiol potent functional antiandrogenic effects mainly due increased shbg levels androgenic activity desogestrel said essentially without clinical indeed combined oral contraceptives containing ethinylestradiol desogestrel found significantly decrease free concentrations testosterone possess overall antiandrogenic effects significantly reducing symptoms acne hirsutism women desogestrel affinity glucocorticoid receptor etonogestrel affinity dexamethasone hence desogestrel etonogestrel weak glucocorticoid typical clinical dosages glucocorticoid activity desogestrel said negligible weak hence clinically however may nonetheless possibly influence vascular function upregulation thrombin receptor observed etonogestrel vascular smooth muscle cells could theory increase coagulation contribute increased risk venous thromboembolism affinity etonogestrel glucocorticoid receptor product methylene substitution substitutions position common feature corticosteroids levonorgestrel etonogestrel without methylene group affinity dexamethasone receptor hence considered negligible glucocorticoid desogestrel etonogestrel affinity estrogen receptor hence estrogenic however metabolite weak affinity estrogen receptor estradiol although significance desogestrel etonogestrel affinity mineralocorticoid receptor hence mineralocorticoid antimineralocorticoid desogestrel etonogestrel show albeit weak inhibition inhibition μm inhibition μm cytochrome enzymes eg halfmaximal inhibitory concentration μm desogestrel stimulates proliferation breast cancer cells vitro action independent classical prs instead mediated via progesterone receptor membrane certain progestins act similarly assay whereas progesterone acts unclear findings may explain different risks breast cancer observed progesterone progestins clinical bioavailability desogestrel found range average significant interindividual variability comparable norethisterone peak concentrations etonogestrel occur hours dose concentrations desogestrel low disappeared hours steadystate levels etonogestrel achieved days daily accumulation etonogestrel thought related progressive inhibition cytochrome monooxygenases eg plasma protein binding desogestrel bound exclusively etonogestrel bound plasma bound albumin shbg free desogestrel bound shbg etonogestrel relatively high affinity plasma protein dihydrotestosterone although considerably less related progestins levonorgestrel neither desogestrel etonogestrel bound corticosteroidbinding desogestrel prodrug etonogestrel upon ingestion rapidly completely transformed metabolite intestines hydroxylation position desogestrel catalyzed cytochrome enzymes intermediates followed oxidation hydroxyl group responsible small percentage desogestrel metabolized levonorgestrel involves removal methylene following metabolism etonogestrel occurs mainly reduction group hydroxylation monooxygenases major metabolite desogestrel desogestrel short terminal halflife hours etonogestrel relatively long elimination halflife hours reflecting nature desogestrel desogestrel etonogestrel eliminated exclusively metabolites urine desogestrel also known synthetic estrane steroid derivative specifically derivative norethisterone member gonane subgroup family desogestrel deketo analogue etonogestrel deketo methylene analogue chemical synthesis desogestrel desogestrel synthesized organon international netherlands first described literature developed following discovery substitutions enhance biological activity desogestrel introduced medical use brand names marvelon desogen along gestodene norgestimate sometimes referred thirdgeneration progestin based time introduction first three thirdgeneration progestins although desogestrel introduced widely used europe time introduced united states desogestrel generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name dcftooltip dénomination commune française dcittooltip denominazione comune italiana jantooltip japanese accepted development known desogestrel marketed variety brand names throughout world including alenvona apri azalia azurette bekyree caziant cerelle cesia cyclessa cyred denise desogen desirett diamilla emoquette enskyce feanolla gedarel gracial isibloom juleber kalliga kariva laurina linessa lovima mircette mirvala novynette orthocept pimtrea reclipsen regulon simliya solia velivet viorele volnea among desogestrel available widely throughout world including united states canada united kingdom ireland many european countries australia new zealand south africa latin america asia united states available combination ethinylestradiol combined oral contraceptive available alone approved uk july desogestrel pills made available purchase without requiring prescription doctor beforehand pharmacists use suitability questionnaire determine medication going suitable person purchase pharmacy online online purchases require suitability questionnaire completed medication sent customer february consumer advocacy group public citizen released petition requesting food drug administration ban oral contraceptives containing desogestrel united states citing studies going far back suggest risk dangerous blood clots doubled women pills comparison oral public citizen released list recommendations included numerous alternative secondgeneration birth control pills women could take place oral contraceptives containing secondgeneration medications market longer shown effective preventing unwanted pregnancy lower risk blood medications cited specifically petition include cyclessa desogen kariva mircette orthocept reclipsen velivet generic pills contain desogestrel combination medications containing desogestrel active ingredient opposed used conjunction ethinylestradiol like combined oral contraceptives show increased thrombosis risk therefore safer secondgeneration birthcontrol pills regards desogestrel studied extensively antigonadotropin use combination testosterone hormonal contraceptive combinations found effective producing reversible azoospermia men reversible azoospermia severe oligozoospermia almost httpsenwikipediaorgwikidesogestrel